Preliminary Results Of A Phase I Clinical Trial Using An Autologous Dendritic Cell Cancer Vaccine Targeting Her2 In Patients With Metastatic Cancer Or Operated High-Risk Bladder Cancer (Nct01730118).
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要